Home
/
Lambda Insights

Insights

Featured Insights

CASE-STUDY

Advancing Breast Cancer Research – Lambda and Novum’s Commitment to Patient-Centric Trials

Blog

Advancing Pediatric Clinical Trials:

Blog

Overcoming Challenges in a Multicenter Oncology Clinical Trial: Study on Bioequivalence Assessment of Doxorubicin Hydrochloride Liposome Injection

Filter By :

Blog

Study Insights: Phase-I, Bioequivalence Study of Trastuzumab SC Injection

Blog

Specialized Clinical Development Support for Semaglutide Programs

News

Bioanalytical Excellence Upheld – Unannounced US FDA inspection concludes with Zero 483s

News

Lambda Successfully Completes US FDA Pharmacovigilance Inspection with Zero 483s – 4th Consecutive in One Year

Clinical Research Update

Clinical Research Update – June 2025

BlogClinical Research

Full-Service CRO | End-to-End Expertise for Every Phase of Clinical Development

Clinical Research Update

Clinical Research Update – May 2025

Case-Study

Insights: Bioequivalence Study of Semaglutide Injection

BlogLabs

Study Insights: Bioequivalence Study of Semaglutide Injection 1.34 mg/ml (2 mg/1.5 mL)

BlogLate Phase

Ovarian Cancer Clinical Trials – Advancing Research Through Patient-Focused Approaches

News

Lambda Ahmedabad Successfully Completes USFDA Inspection without any 483 Observations

Early PhaseServices & Capabilities

End-to-End BA BE Studies Expertise

BiosimilarServices & Capabilities

End-to-end Biosimilar Development and Clinical Trials Expertise

Late PhaseServices & Capabilities

Advancing Late Phase Clinical Trials

Clinical Research Update

Clinical Research Update – April 2025

BlogLate Phase

Strategic Endpoint Selection for Successful Oncology Clinical Trials

BlogClinical Research

Navigating CDSCO Regulations: Key Approval Processes and Lambda’s Regulatory Support

News

USFDA Approves ANDA for Protein-Bound Paclitaxel Injection: Program supported by Lambda as the key Bioanalytical Partner

BlogLate Phase

Advancing Clinical Development in Women’s Health

BlogLabs

A Highly Precise, Accurate, and Robust LC-MS/MS Method for the Quantification of Semaglutide in Human Plasma

News

Lambda Successfully Completes Multi-Site EMA Inspection for Biosimilar Product

Clinical Research Update

Clinical Research Update – March 2025

News

Lambda Successfully Completes Swissmedic Inspection for Pharmacovigilance Services

Clinical Research Update

Clinical Research Update – February 2025

News

Successful completion of the Ministry of Health inspection of the Republic of Kazakhstan (October 2024)

BlogLate Phase

Patient-Centric Trials in Advancing Cancer Research: A Journey of Progress & Hope

BlogPharmacovigilance

Ensuring Drug Safety: Lambda’s Pharmacovigilance Milestones in 2024

Clinical Research Update

Clinical Research Update – January 2025

News

Lambda Excels in US FDA Inspection for PV with Zero Findings – 3rd Success in 2024

BlogEarly Phase

Nutraceuticals and Consumer Products Studies: Ensure product safety & efficacy with expert-led trials

BlogLate Phase

Advancing Prostate Cancer Clinical Trials: Key Insights

Clinical Research Update

Clinical Research Update – Lambda Newsletter – December 2024

BlogLabs

Summation of Similar Product Ions for Improved LC-MS-MS Quantitation: Advancing Peptide Analysis

BlogClinical Research

What are Clinical Trials? Unlocking the Basics and the Critical Importance

Clinical Research Update

Understanding Clinical Trials: A Beginner’s Guide to Clinical Research

BlogLate Phase

Advancing Lung Cancer Clinical Trials

BlogPharmacovigilance

Efficient ICSR Management and Regulatory Compliance for Bulk Case Handling

BlogLate Phase

Breast Cancer Clinical Trials – Transforming Lives Through Patient-Centric Trials

Clinical Research Update

Addressing Top Clinical Research FAQs for Pharma and Biotech

BlogPharmacovigilance

Ensuring PV Quality Assurance: A Comprehensive Approach

Let's Unveil New Therapies Together

Connect with our experts to leverage our proven track record of clinical research excellence.